K. Tanimura
Nippon Medical School
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by K. Tanimura.
Diabetes Research and Clinical Practice | 2008
K. Tanimura; Yasushi Nakajima; Mototugu Nagao; Akira Ishizaki; Toshiko Kano; Taro Harada; Fumitaka Okajima; Mariko Sudo; Hideki Tamura; Shinya Ishii; Hitoshi Sugihara; Shizuya Yamashita; Akira Asai; Shinichi Oikawa
AIMS The atherogenicity of chylomicron remnants has been discussed. We examined whether serum apoB48 level is associated with the presence of carotid plaque in type 2 diabetic patients. METHOD Forty type 2 diabetic patients (21 males and 19 females, 52.8+/-11.8 years old; mean+/-S.D.) were divided into two groups by the presence or absence of carotid plaque. The diurnal change of serum apoB48 level was measured by enzyme-linked immunosorbent assay. RESULTS Fasting serum apoB48 level was higher in the subjects with carotid plaque than those without (6.5+/-3.8vs. 4.1+/-1.9 microg/ml, p=0.01). Age- and gender-adjusted analysis showed that the presence of carotid plaque was associated with fasting apoB48 (OR 1.43; 95% CI, 1.07-2.09, p=0.04) and triglyceride (OR 1.14; 95% CI, 1.02-1.32, p=0.04) levels. In normal LDL-cholesterol (<140 mg/dl) subjects, the presence of carotid plaque was associated with fasting apoB48 level (OR 2.16; 95% CI, 1.22-5.32, p=0.04), but not associated with fasting triglyceride level (OR 1.11; 95% CI, 0.99-1.30, p=0.13). CONCLUSIONS Serum apoB48 level was strongly associated with the presence of carotid plaque in type 2 diabetic patients.
Journal of Diabetes Investigation | 2012
Mototsugu Nagao; Akira Asai; Momoyo Kawahara; Yasushi Nakajima; Yuki Sato; K. Tanimura; Fumitaka Okajima; Makiyo Takaya; Mariko Sudo; Shuji Takemitsu; Taro Harada; Hitoshi Sugihara; Shinichi Oikawa
Aims/Introduction: The development of type 2 diabetes is primarily due to lifestyle and environmental factors, as well as genetics, as shown by familial clustering. To establish mouse lines for evaluating heritable factors determining susceptibility to diet‐induced diabetes, we performed selective breeding for differences in high fat diet (HFD)‐induced glucose intolerance.
Journal of Lipid Research | 2009
Akira Asai; Fumitaka Okajima; Kiyotaka Nakagawa; Daigo Ibusuki; K. Tanimura; Yasushi Nakajima; Mototsugu Nagao; Mariko Sudo; Taro Harada; Teruo Miyazawa; S. Oikawa
Biochimica et Biophysica Acta | 2005
Fumitaka Okajima; Mikiko Kurihara; Chihaya Ono; Yasushi Nakajima; K. Tanimura; Hitoshi Sugihara; Atsushi Tatsuguchi; Kiyotaka Nakagawa; Teruo Miyazawa; Shinichi Oikawa
Journal of Atherosclerosis and Thrombosis | 2010
Yasushi Nakajima; Kazumi Sato; Mariko Sudo; Mototsugu Nagao; Toshiko Kano; Taro Harada; Akira Ishizaki; K. Tanimura; Fumitaka Okajima; Hideki Tamura; Hitoshi Sugihara; Kinsuke Tsuda; Shinichi Oikawa
Atherosclerosis Supplements | 2010
Mariko Sudo; S. Takemitsu; Y. Sato; Mototsugu Nagao; Taro Harada; Yasushi Nakajima; K. Tanimura; Fumitaka Okajima; S. Oikawa
Atherosclerosis Supplements | 2009
K. Tanimura; Mototsugu Nagao; S Mariko; Taro Harada; Yasushi Nakajima; Fumitaka Okajima; Akira Asai; H Kotake; O Shinichi
Atherosclerosis Supplements | 2008
K. Tanimura; Mototsugu Nagao; Yasushi Nakajima; Mariko Sudo; Toshiko Kano; Akira Ishizaki; Taro Harada; Fumitaka Okajima; Hideki Tamura; Shinya Ishii; Hitoshi Sugihara; S. Oikawa
Atherosclerosis Supplements | 2008
Mototsugu Nagao; Yasushi Nakajima; Mariko Sudo; Toshiko Kano; Akira Ishizaki; Taro Harada; K. Tanimura; Fumitaka Okajima; Hideki Tamura; Shinya Ishii; Hitoshi Sugihara; Akira Asai; S. Oikawa
Atherosclerosis Supplements | 2008
Akira Asai; Fumitaka Okajima; K. Tanimura; Yasushi Nakajima; Mototsugu Nagao; Kiyotaka Nakagawa; Teruo Miyazawa; S. Oikawa